Aerovate Therapeutics
AVTE
#9169
Rank
S$99.1 M
Marketcap
$3.43
Share price
0.00%
Change (1 day)
-87.63%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$14.18 Million

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are S$14.18 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$11.47 M188.16%
2021-12-31S$3.98 M-83.34%
2020-12-31S$23.89 M147.6%
2019-12-31S$9.64 M